The revenue declined to Rs. 9056.10 millions for the quarter ended September 2022 as compared to Rs. 9157.70 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 1935.60  millions for the quarter ended September 2022 from Rs. 1875.60 millions of corresponding previous quarter.The company reported a good operating profit of 2790.80 millions compared to 2690.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 9056.10 9157.70 -1.11 16350.70 16176.10 1.08 32175.10 29204.70 10.17
Other Income 221.60 150.50 47.24 499.50 467.80 6.78 762.20 1101.90 -30.83
PBIDT 2790.80 2690.50 3.73 4548.00 4325.20 5.15 8320.50 7079.60 17.53
Interest 3.90 3.50 11.43 10.70 11.40 -6.14 19.90 35.30 -43.63
PBDT 2786.90 2687.00 3.72 4537.30 4313.80 5.18 8416.40 5318.30 58.25
Depreciation 163.60 174.30 -6.14 321.80 349.70 -7.98 681.90 786.00 -13.24
PBT 2623.30 2512.70 4.40 4215.50 3964.10 6.34 7734.50 4532.30 70.65
TAX 687.70 637.10 7.94 1123.60 1022.50 9.89 3968.70 1665.40 138.30
Deferred Tax -46.30 -37.80 22.49 -81.00 -72.60 11.57 -105.00 78.70 -233.42
PAT 1935.60 1875.60 3.20 3091.90 2941.60 5.11 3765.80 2866.90 31.35
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 30.82 29.38 4.89 27.82 26.74 4.03 25.86 24.24 6.68

Glaxosmithkline Phar Share Price

2447.05 -17.85 (-0.72%)
29-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.60
Dr. Reddys Lab 1262.95
Cipla 1501.80
Zydus Lifesciences 905.45
Lupin 2092.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×